Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
ASSETS
Total Assets
Current Liabilities:
Accounts payable	326,400	316,400
Accrued interest	1,150,820	1,193,596
Accrued officer compensation	292,000	172,000
Notes payable, net of discounts of $77,004 and $35,547, respectively	1,391,432	1,693,848
Derivative liabilities	2,140,159	472,605
Loans payable	254,500	254,500
Total Current Liabilities	5,555,311	4,102,949
Total Liabilities	5,555,311	4,102,949
Commitments and Contingencies (Note 9)
STOCKHOLDERS’ DEFICIT:
Series A Preferred stock, 3,500,000 shares authorized, par value $0.01; 3,381,520 shares issued and outstanding	33,815	33,815
Series B Preferred stock, 10,000 shares authorized, par value $0.01; 5,000 shares issued and outstanding	50	50
Series C Preferred stock, 10,000,000 shares authorized, par value $0.01; 5,000,000 shares issued and outstanding	50,000	50,000
Series D Preferred stock, 125,000 shares authorized, par value $0.0001; 125,000 shares issued and outstanding	12	12
Series E Preferred stock, 500,000 shares authorized, par value $0.01; 34,985 and 53,000 shares issued and outstanding; respectively	34,985	34,985
Series E Preferred stock to be issued	166,331	140,831
Total preferred stock	285,194	259,694
Common stock 3,000,000,000 shares authorized, $0.00001 par value; 1,339,044,282 and 297,041,945 shares issued and outstanding, respectively at December 31, 2020 and December 31,2019	13,390	2,970
Treasury stock, at cost - 2,917 shares	(773,500)	(773,500)
Additional paid in capital	76,679,297	75,958,049
Accumulated deficit	(81,759,691)	(79,575,663)
Total Stockholders’ Deficit	(5,555,311)	(4,102,909)
Total Liabilities and Stockholders’ Deficit